Literature DB >> 27160662

Epigenetic Regulation of Adaptive NK Cell Diversification.

Bianca Tesi1, Heinrich Schlums2, Frank Cichocki3, Yenan T Bryceson4.   

Abstract

Natural killer (NK) cells were previously considered to represent short-lived, innate lymphocytes. However, mouse models have revealed expansion and persistence of differentiated NK cell subsets in response to cytomegalovirus (CMV) infection, paralleling antigen-specific T cell differentiation. Congruently, analyses of humans have uncovered CMV-associated NK cell subsets characterized by epigenetic diversification processes that lead to altered target cell specificities and functional capacities. Here, focusing on responses to viruses, we review similarities and differences between mouse and human adaptive NK cells, identifying molecular analogies that may be key to transcriptional reprogramming and functional alterations. We discuss possible molecular mechanisms underlying epigenetic diversification and hypothesize that processes driving epigenetic diversification may represent a more widespread mechanism for fine-tuning and optimization of cellular immunity.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  NK cells; adaptive immunity; cellular diversification; epigenetic regulation; infection

Mesh:

Year:  2016        PMID: 27160662     DOI: 10.1016/j.it.2016.04.006

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  27 in total

Review 1.  Diversification of human NK cells: Lessons from deep profiling.

Authors:  Aaron J Wilk; Catherine A Blish
Journal:  J Leukoc Biol       Date:  2018-01-19       Impact factor: 4.962

Review 2.  Mutually assured destruction: the cold war between viruses and natural killer cells.

Authors:  Ayad Ali; Ivayla E Gyurova; Stephen N Waggoner
Journal:  Curr Opin Virol       Date:  2019-03-13       Impact factor: 7.090

3.  Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells.

Authors:  Heinrich Schlums; Moonjung Jung; Hongya Han; Jakob Theorell; Venetia Bigley; Samuel C C Chiang; David S J Allan; Jan K Davidson-Moncada; Rachel E Dickinson; Tim D Holmes; Amy P Hsu; Danielle Townsley; Thomas Winkler; Weixin Wang; Pål Aukrust; Ingvild Nordøy; Katherine R Calvo; Steve M Holland; Matthew Collin; Cynthia E Dunbar; Yenan T Bryceson
Journal:  Blood       Date:  2017-02-16       Impact factor: 22.113

Review 4.  The Broad Spectrum of Human Natural Killer Cell Diversity.

Authors:  Aharon G Freud; Bethany L Mundy-Bosse; Jianhua Yu; Michael A Caligiuri
Journal:  Immunity       Date:  2017-11-21       Impact factor: 31.745

Review 5.  Natural killer cell education in human health and disease.

Authors:  Jeanette E Boudreau; Katharine C Hsu
Journal:  Curr Opin Immunol       Date:  2018-02-03       Impact factor: 7.486

6.  LILRB1 polymorphisms influence posttransplant HCMV susceptibility and ligand interactions.

Authors:  Kang Yu; Chelsea L Davidson; Agnieszka Wójtowicz; Luiz Lisboa; Ting Wang; Adriana M Airo; Jean Villard; Jeremie Buratto; Tatyana Sandalova; Adnane Achour; Atul Humar; Katia Boggian; Alexia Cusini; Christian van Delden; Adrian Egli; Oriol Manuel; Nicolas Mueller; Pierre-Yves Bochud; Deborah N Burshtyn
Journal:  J Clin Invest       Date:  2018-03-12       Impact factor: 14.808

7.  CD56dim CD57- NKG2C+ NK cells retaining proliferative potential are possible precursors of CD57+ NKG2C+ memory-like NK cells.

Authors:  Polina A Kobyzeva; Maria A Streltsova; Sofya A Erokhina; Leonid M Kanevskiy; William G Telford; Alexander M Sapozhnikov; Elena I Kovalenko
Journal:  J Leukoc Biol       Date:  2020-09-15       Impact factor: 6.011

Review 8.  Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbs.

Authors:  Cristina Capuano; Chiara Pighi; Simone Battella; Davide De Federicis; Ricciarda Galandrini; Gabriella Palmieri
Journal:  Cancers (Basel)       Date:  2021-05-20       Impact factor: 6.639

9.  Tumor-Targeting Anti-CD20 Antibodies Mediate In Vitro Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and In Vivo Priming.

Authors:  Cristina Capuano; Simone Battella; Chiara Pighi; Lavinia Franchitti; Ombretta Turriziani; Stefania Morrone; Angela Santoni; Ricciarda Galandrini; Gabriella Palmieri
Journal:  Front Immunol       Date:  2018-05-11       Impact factor: 7.561

10.  Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C+ NK cells to target myeloid leukemia.

Authors:  Emily Chiu; Martin Felices; Frank Cichocki; Zachary Davis; Hongbo Wang; Katie Tuninga; Daniel A Vallera; Tom Lee; Ryan Bjordahl; Karl Johan Malmberg; Bahram Valamehr; Jeffrey S Miller
Journal:  Mol Ther       Date:  2021-06-24       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.